Latest lung disease News | Page 5

Premature baby Charlotte is mango-sized miracle
Smoking is the leading cause of chronic obstructive pulmonary disease
Major retailers join Queensland’s engineered stone campaign
Pivotal role of TLR7 protein revealed in lung disease
Are you silica smart?
AWU welcomes Safe Work recommendation to ban engineered stone
Cumberland Council encourages residents to stay informed about the dangers of asbestos this November for National Asbestos Awareness Month
About 100 people a month are diagnosed with lung cancer in WA
Australia’s tenth annual National Asbestos Awareness Month launches new Asbestos Education resource for residential property owners, managers and tradies to help save lives
Multi-million dollar boost into child research programs
PHAA backs ban on engineered stone products
Datopotamab deruxtecan improved progression-free survival vs. chemotherapy in patients with previously treated non-small cell lung cancer in TROPION-Lung01 Phase III trial
Datopotamab deruxtecan significantly extended progression-free survival vs. chemotherapy in patients with HR-positive, HER2-low or negative breast cancer in TROPION-Breast01 Phase III trial
Datopotamab deruxtecan plus Imfinzi demonstrated robust and durable tumour responses in 1st-line treatment of patients with metastatic triple-negative breast cancer in BEGONIA…
Breakthrough in understanding immune responses in inflammatory bowel and lung disease
COVID-19 first infectious disease in top 5 causes of death since 1970
Accelerated silicosis update
Datopotamab deruxtecan demonstrated statistically significant and clinically meaningful progression-free survival benefit in patients with HR-positive, HER2-low or negative breast cancer in TROPION-Breast01…
Delivering hope: anti-inflammatory drug trial for preterm babies
Datopotamab deruxtecan plus Imfinzi showed promising clinical activity in the first-line advanced non-small cell lung cancer setting in TROPION-Lung04 Phase Ib trial
Outback dad celebrates Father’s Day with pint-sized Jack
Mater Foundation partners with Nine Network for exciting new five year partnership
Extending Dedicated Care For Workers At Risk Of Silicosis
Ozempic is in the spotlight but it’s just the latest in a long and strange history of weight-loss drugs
Enhertu demonstrated clinically meaningful progression-free survival and overall survival across multiple HER2-expressing advanced solid tumours in DESTINY-PanTumor02 Phase II trial
$1.1 million for breakthrough lung disease scanner
Breakthrough lung disease scanner
Omega-3 fatty acids promising for maintaining lung health
Spotlight shines on research and innovation projects
Keep your lungs strong and healthy this winter with Lung Foundation Australia
Retired miners urged to get free lung health checks
Mater launches clinical trial to protect preterm babies
Rainforest plant could hold key to lung fibrosis treatment
Device that can remotely monitor your breathing: as tested on cane toads
Engineered stone may break my bones, but its dust will hurt workers’ lung
Datopotamab deruxtecan combinations showed encouraging tumour responses in patients with advanced non-small cell lung cancer in TROPION-Lung02 Phase Ib trial
People who smoke urged to prioritise healthy food not tobacco
Funding for early screening and improved treatments for deadly lung disease
Calls intensify for ban on lethal engineered stone
Major CFMEU rallies across Australia to hit streets as anger rises
Our Make Smoking History team launch ‘Sounds Like’ campaign
Major government funding for Greater Manchester innovation in materials, health and AI
Team Discovers how TKI Cancer Drugs Cause Inflammatory Side Effects
Malfunctioning immune cell behaviour could be drug target in Long Covid
Call for Manchester volunteers in dementia/Alzheimer’s pollution link study
Victoria Backs National Ban On Deadly Engineered Stone
Statement on WHS Ministers’ Meeting
Children’s lung capacity improved in cleaner air